Shandong Sito Bio-technology Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Lianbiao Jin

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	sin datos

Actualizaciones recientes de la dirección

Recent updates

Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%

Apr 16

CEO

Lianbiao Jin (58 yo)

no data

Permanencia

Mr. Lianbiao Jin is General Manager of Shandong Sito Bio-technology Co., Ltd.

Shandong Sito Bio-technology Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

Less than half of directors are independent

Recent updates

Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%

Investor sentiment deteriorates as stock falls 20%

Shandong Sito Bio-technology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 16%

Shandong Sito Bio-technology Co., Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024

Investor sentiment improves as stock rises 21%

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.066 (vs CN¥0.053 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

New major risk - Share price stability

New major risk - Shareholder dilution

Investor sentiment deteriorates as stock falls 44%

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.18 in 2Q 2022)

Shandong Sito Bio-technology Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023

Shandong Sito Bio-Technology Co., Ltd. Approves Cash Dividend/10 Shares for 2022

First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.12 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.084 (vs CN¥0.12 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.23 in 2Q 2021)

Investor sentiment improved over the past week

Shandong Sito Bio-Technology Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 05 July 2022

Shandong Sito Bio-technology Co., Ltd. announced that it expects to receive CNY 298.0822 million in funding

Shandong Sito Bio-technology Co., Ltd. Approves Cash Dividend for the Year 2021

Shandong Sito Bio-Technology Co., Ltd. Proposes Final Dividend for 2021

First quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.05 loss in 1Q 2021)

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.12 loss in 2Q 2020)

Shandong Sito Bio-Technology Co., Ltd. Omits to Pay Dividend for the Year 2020

First quarter 2021 earnings released: CN¥0.05 loss per share (vs CN¥0.23 loss in 1Q 2020)

Shandong Sito Bio-technology Co., Ltd. to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day low: CN¥19.49

New 90-day low: CN¥23.14

New 90-day low: CN¥26.06

New 90-day low: CN¥28.21

Third quarter earnings released

New 90-day high: CN¥31.63

First half earnings released

Shandong Sito Bio-technology Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Permanencia